Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Amgen
National Institutes of Health Clinical Center (CC)
University of Michigan Rogel Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Baptist Health South Florida
Kyowa Kirin Co., Ltd.
Amgen
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Daiichi Sankyo
Stanford University
Therapeutic Advances in Childhood Leukemia Consortium
SWOG Cancer Research Network
Karyopharm Therapeutics Inc
Fred Hutchinson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
ADC Therapeutics S.A.
Children's Oncology Group
Fred Hutchinson Cancer Center
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Novartis
ADC Therapeutics S.A.
Northwestern University
Fred Hutchinson Cancer Center
Eli Lilly and Company
Therapeutic Advances in Childhood Leukemia Consortium
Merck Sharp & Dohme LLC
Dartmouth-Hitchcock Medical Center
MedImmune LLC
Massachusetts General Hospital
Merck Sharp & Dohme LLC
Otsuka Pharmaceutical Co., Ltd.
Swedish Orphan Biovitrum